CDMOs and CROs at BIO‑Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
37 CDMOs and CROs are at BIO-Europe 2026 — 27 presentations on the program and 1 with a booth in the exhibit hall. Most represented: Evotec (2 on the program), Lonza (2 on the program), BeNatureBioLab (2 on the program). 16 of them have their own page in this guide. As of Sep 29, 2026.
Track
Top represented
Showing 1–19 of 37 organizations
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Evotec Hamburg, Germany | ◆Platinum Sponsor |
Drug discovery and development partner providing research services and biologics development and manufacturing to pharma and biotech. | Panel Tue Nov 10 17:00–17:45 Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World How drug companies are reshaping research and manufacturing partnerships to stay reliable as political tensions and supply chain risks divide the world. Business of BiotechBiomanufacturing Strategy Panel Wed Nov 11 09:00–10:00 Collaborative Innovation in CDMO Partnerships How drug companies and contract manufacturers develop new therapies together, with examples of what makes these partnerships work and where they struggle. |
Lonza Basel, Switzerland | ◆Platinum Sponsor |
Contract development and manufacturing organization for biologics, small molecules, and cell and gene therapies. | Panel Mon Nov 9 15:30–15:55 Beyond the Race to IND: Balancing Speed, Risk and Future Value When racing to first human trials pays off for a biotech, and when that speed creates risks for manufacturing and growth later on. Panel Tue Nov 10 15:00–15:25 Scaling Biologics Manufacturing in a Changing World: How Biopharma is Rethinking Launches, Partnerships and Resilience How political uncertainty and trade shifts are changing how drug companies pick outside manufacturers, including whether to produce closer to home. |
BeNatureBioLab Chuncheon, South Korea | |
Provides formulation development and contract manufacturing for functional foods, cosmetics and pharmaceuticals using hot-melt extrusion drug delivery technology. | Panel Tue Nov 10 14:00–14:30 Korea's Next Wave: Biotech Innovators to Watch Korean biotechs present work spanning drug formulation, safety testing, the microbiome, mRNA and gene therapy delivery, and engineered toxins for cosmetic use. |
Avid Bioservices Tustin, California | ◆Platinum Sponsor |
CDMO providing process development and clinical and commercial manufacturing of mammalian cell culture biologics and viral vectors. | Panel Tue Nov 10 09:00–09:25 The Future of Biopharmaceutical Manufacturing How biotech drug makers can scale up from trial batches to full production, and where automation, AI and sustainability fit in. |
Parexel Durham, NC | ◆Platinum Sponsor |
Clinical research organization providing clinical development, regulatory consulting and market access services to biopharmaceutical companies. | Panel Tue Nov 10 14:00–14:25 Navigating the Evolving Regulatory Landscape: Strategies for Clinical Success in an Era of Transformation How rare disease drugs can win approval with few patients, how FDA leadership changes shift priorities, and how real-world data can strengthen applications. |
WuXi AppTec Shanghai, China | ◆Platinum Sponsor |
Contract research, development and manufacturing organization serving pharma and biotech across small molecules, oligonucleotides, peptides and other modalities. | Panel Tue Nov 10 17:00–17:45 Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World How drug companies are reshaping research and manufacturing partnerships to stay reliable as political tensions and supply chain risks divide the world. Business of BiotechBiomanufacturing Strategy |
AB Agilex Biolabs Adelaide, Australia | |
Australian bioanalytical laboratory providing regulated bioanalysis, toxicology and immunology testing for clinical trials. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
Alithia Life Sciences Melbourne, Australia | |
Australian clinical research consultancy supporting Phase I to III trials with project and site management, monitoring and data management. | Panel Wed Nov 11 09:55–10:25 What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide. |
Avion CRO Melbourne, Australia | |
Australian contract research organization specializing in imaging for clinical trials, including central reads, dosimetry and radiopharmaceutical studies. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
B BioCina Adelaide, Australia | |
Australian CDMO manufacturing microbial biologics, plasmid DNA and mRNA for clinical and commercial supply. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
Cancer Trials Australia Melbourne, Australia | |
Not-for-profit network of Australian and New Zealand hospital sites and research institutes providing oncology clinical trial management services. | Panel Wed Nov 11 09:55–10:25 What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide. |
Cellistic Mont-Saint-Guibert, Belgium | |
Contract development and manufacturing organization for cell therapies derived from induced pluripotent stem cells (iPSCs). | Talk Wed Nov 11 10:30–11:00 From Innovation to Scalable Manufacturing: Closing the Gap Biotechs, researchers and contract manufacturers discuss what it takes to scale a new therapy into a product made reliably under strict quality rules. |
CMAX Clinical Research Adelaide, Australia | |
Australian early-phase clinical trial unit running first-in-human and other early-phase studies for sponsors. | Panel Wed Nov 11 09:55–10:25 What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide. |
Crux Biolabs Melbourne, Australia | |
Bioanalytical contract research organization providing immunology and biomarker laboratory services for clinical trials. | Panel Wed Nov 11 09:55–10:25 What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide. |
FC FGK Clinical Research Munich, Germany | |
German contract research organization running clinical trials for pharma, biotech and medical device companies. | Panel Tue Nov 10 09:30–09:55 Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off Five teams from Germany's biotech scene, which spans university research, companies, drug manufacturing and healthcare, show their work and its impact. |
Just – Evotec Biologics Seattle, WA | |
Evotec's biologics development and manufacturing business, running continuous-manufacturing J.POD facilities. | Panel Wed Nov 11 10:00–10:30 A Highly Intensified Manufacturing Platform for Rapid Development of Next-Generation Biologics How Just-Evotec grows cells at very high density to make hard-to-express proteins and speed complex multi-target antibodies into early trials. |
Australian provider of storage, labelling, packaging and distribution of clinical trial materials in Asia-Pacific. | Panel Tue Nov 10 14:30–15:00 Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept. |
N nagene Vienna, Austria | |
Vienna start-up producing custom synthetic DNA, including GMP-grade DNA used to make mRNA medicines. | Talk Mon Nov 9 15:00–16:15 Merck's EMEA Advance Biotech Grant Program Five young biotech companies pitch their science to Merck, competing for a grant that helps them bring a product to market. |
Optimapharm Zagreb, Croatia | |
Independent clinical research organization founded in Zagreb, running trials across Central, Eastern and Western Europe. | Panel Tue Nov 10 15:30–15:55 Unlocking Europe as a Clinical Trials Hub: Delivering Trials at Scale Through Strategic Site Optimization and Operational Excellence How to run large clinical trials across Europe's varied health systems, from picking trial sites to faster study start-up and cross-border logistics. |
Instantly find 20 buyers from CDMOs and CROs
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse BIO-Europe 2026 by
Organization type
Track
Everyone
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction